COVID-19: NSA to be lodged against 3 for selling Remdesivir at higher rates in U.P.

The recovered injections, which cost around ₹5,400 each, did not have any batch number or other details, the STF said.

April 16, 2021 08:47 am | Updated 08:47 am IST - LUCKNOW:

Remdesivir antiviral injectable drug. File

Remdesivir antiviral injectable drug. File

Police in Uttar Pradesh’s Kanpur have said they will slap the National Security Act (NSA) against three persons who were arrested on charges of allegedly smuggling and selling Remdesivir , an injectable drug used in the treatment of COVID-19, at rates higher than in the market.

Also read: Centre bans export of Remdesivir

The arrests come two days after the State government urgently procured 25,000 vials of Remdesivir from Gujarat due to the rise in number of cases and demand for the drug.

The Uttar Pradesh Special Task Force (STF) said they recovered 265 vials of Covifor injection (Remdesivir) which the accused persons were smuggling.

The action came after intelligence inputs that since there was a shortage of Remdesivir in local markers “drug smugglers” were selling it at a much higher price, the Uttar Pradesh, STF which carried out the operation, said.

The recovered injections, which cost around ₹5,400 each, did not have any batch number or other details, it said.

Aseem Arun, Kanpur Police Commissioner, said the stringent NSA would be lodged against the accused as “it was a crime against humanity”.

The police were trying to identify all those involved in the sourcing and trade of the drug, he said in a tweet shared by Kanpur police.

The arrested persons were identified as Mohan Soni, Prashant Shukla and Sachin Kumar. Soni and Shukla are medical representatives, the STF said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.